IV Ketamine Therapy for Depression

IV Therapy for Depression

IV therapy is a physician-directed medical treatment that may be considered for adults living with certain depressive disorders, particularly when standard treatments have not provided sufficient benefit.
Ketamine has been authorized in Canada for use as an anesthetic for many years. Its use in depression involves lower, sub-anesthetic doses administered under medical supervision. While research is ongoing, clinical studies suggest that ketamine may reduce depressive symptoms in some individuals.

Who May Be Considered for Treatment

IV therapy may be considered for adults with:
Treatment suitability is determined only after a comprehensive medical and psychiatric assessment.
IV therapy is not considered a first-line treatment for depression.

Regulatory Information

In Canada, ketamine is approved as an anesthetic medication. The use of IV therapy for depression is considered an off-label medical use, meaning it is prescribed based on clinical judgment and available scientific evidence but is not specifically authorized by Health Canada for this indication.
Patients will be informed of this status during the consent process.

How It Works

Ketamine acts on the brain’s glutamate system, which plays a role in mood regulation and neural connectivity. Research suggests it may promote changes in neural signaling associated with depressive symptoms.
Some patients report improvement within hours to days; however:

What to Expect

Initial Assessment

A physician will review:
If appropriate, an individualized treatment plan will be developed.

Infusion Appointment

Patients must arrange transportation home and should not drive or operate machinery until the following day.

Treatment Course

A typical initial course may include multiple infusions over several weeks. The number and frequency of treatments are determined by clinical response and physician assessment.
Maintenance treatments, if considered, are individualized.

Potential Risks and Side Effects

When administered in a controlled medical setting, IV ketamine is generally well tolerated. However, risks may include:
Common, short-term effects:
Long-term safety data for repeated use in depression are still evolving.
All risks, benefits, and alternatives are reviewed prior to treatment.

Coverage and Fees

IV ketamine therapy for depression is not covered by OHIP (Ontario Health Insurance Plan).
As this treatment is not publicly funded for this indication, services are typically provided on a private, fee-for-service basis. Patients are responsible for associated costs unless private insurance coverage applies.
Patients are encouraged to verify coverage with their individual insurer.

Important Information

IV therapy is not a cure for depression. It may reduce symptoms in some individuals, and results vary.
This treatment should be part of a comprehensive mental health care plan, which may include psychotherapy, medication management, and ongoing psychiatric follow-up.
If you are experiencing thoughts of self-harm or are in crisis, call 911 or attend your nearest emergency department immediately
Scroll to Top